Cargando…
Delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema
BACKGROUND: Lymphedema is a chronic disease results from impaired flow of the lymphatic system. Therefore, reconstruction of lymphatic system is crucial to treat limb lymphedema. Vascular endothelial growth factor (VEGFC) has been reported to be an important regulator involved in the growth and diff...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729376/ https://www.ncbi.nlm.nih.gov/pubmed/33313243 http://dx.doi.org/10.21037/atm-20-6605 |